Washington (US): According to a new study from scientists at Scripps Research, the anxiety that occurs during withdrawal from excessive alcohol use, and contributes to relapse, may be driven in part by the release of an immune protein in the brain.
The discovery, reported online on June 6, 2022, in Molecular Psychiatry, illuminates the molecular details of the brain's response to alcohol withdrawal, and suggests that the immune protein, colony-stimulating factor 1 (CSF1), could be a target of future treatments for alcohol use disorder (AUD).
